Skip to content
10-K

Annual Report

LifeStance Health Group, Inc. LFST

0000950170-25-029100

← back to feed
Filed
Feb 27, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 19, 2025 384.55M sh
Long Term Debt FY 2024 · Dec 31, 2023 $280.29M
Short Term Debt FY 2024 · Dec 31, 2023 $2.93M
Cash And Equivalents FY 2024 · Dec 31, 2023 $78.82M
Stockholders Equity FY 2024 · Dec 31, 2023 $1.43B
Current Liabilities FY 2024 · Dec 31, 2023 $202.87M
Total Liabilities FY 2024 · Dec 31, 2023 $681.04M
Current Assets FY 2024 · Dec 31, 2023 $225.73M
Total Assets FY 2024 · Dec 31, 2023 $2.11B
Shares Diluted restated FY 2024 · Dec 31, 2022 355.28M sh
Capex FY 2024 · Dec 31, 2022 $79.26M
Operating Cash Flow FY 2024 · Dec 31, 2022 $52.79M
Sga Expense FY 2024 · Dec 31, 2022 $377.99M
Net Income FY 2024 · Dec 31, 2022 −$215.56M
Operating Income FY 2024 · Dec 31, 2022 −$210.17M